Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study of Effects of 'Seroquel-XR' on the Improvement of Neurocognitive Function in People At-risk Mental States(ARMS)

NCT01250847 is registered in ClinicalTrials.gov with Severance Hospital as lead sponsor.

NCT NCT01250847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01250847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study of Effects of 'Seroquel-XR' on the Improvement of Neurocognitive Function in People At-risk Mental States(ARMS)
Lead sponsor
Severance Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2010
Completion date
October 31, 2012
Enrollment
83 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

abnormal mental state, schizophrenia